Literature DB >> 9332004

Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force.

T Yao1, M Yamada, H Yamahara, M Yoshida.   

Abstract

Formulation of sustained release tablets containing coated particles whose coating membrane is not damaged during compression was studied and several kinds of chitosan of different particle size were evaluated as protective agents for the membrane. Comparison was made with the dissolution rate of the coated particles. Ethylcellulose or ethylcellulose/hydroxypropylcellulose was chosen as a coating agent. When the coated particles were compressed with the small particle size chitosan (Marine Chito), the coating membrane was not ruptured, and the protective effect was not influenced by the compression pressure. Both the Eudragit RS-coated particles and the tablets manufactured by compressing the coated particles with Marine Chito were orally administered to dogs, and the plasma theophylline levels of the two dosage forms were compared to determine the drug release characteristics in the gastrointestinal tract. It was found that the plasma concentration-time curve of the tablets coincided with that of the coated particles, and the compressed tablet would disintegrate instantly and redisperse into many particles in the body after oral administration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9332004     DOI: 10.1248/cpb.45.1510

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Evaluation of powder and tableting properties of chitosan.

Authors:  Katharina M Picker-Freyer; Diana Brink
Journal:  AAPS PharmSciTech       Date:  2006-09-08       Impact factor: 3.246

2.  Effect of polysulfonate resins and direct compression fillers on multiple-unit sustained-release dextromethorphan resinate tablets.

Authors:  Thaned Pongjanyakul; Aroonsri Priprem; Padungkwan Chitropas; Satit Puttipipatkhachorn
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.